Virtus Fund Advisers, LLC
- SEC CIK
- 0001319111
- Latest filing
- Feb 14, 2025
CPRX holding history
Catalyst Pharmaceuticals, Inc. in every 13F filed by Virtus Fund Advisers, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CPRX overviewAll 13F holders of CPRXFull Q4 2024 holdings
- Shares (Q4 2024)
- 1,340
- Value
- $28.0K
- % of portfolio
- 0.1%
- Quarters held
- 8
- Since Q1 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2024 | 1,340 | $28.0K | 0.1% | +46+3.6% | Added | Holders |
| Q3 2024 | 1,294 | $25.7K | 0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 1,294 | $20.0K | 0.1% | +266+25.9% | Added | Holders |
| Q1 2024 | 1,028 | $16.4K | 0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 1,028 | $17.3K | 0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 1,028 | $12.0K | 0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 1,028 | $13.8K | 0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 1,028 | $17.0K | 0.1% | +1,028 | New | Holders |